News

The stock is trading near 52-week highs, but under the surface, commercial segment cost trends are creating headwinds.

Tempus AI’s planned acquisition follows recent interest in blood-based cancer tests across the medtech industry.

Truist, Oppenheimer and KeyBanc moved to $500 targets, with Oppenheimer saying UnitedHealth “handily” beat expectations.

UnitedHealth Group (UNH) beat Wall Street's numbers on July 16, 2026, but its chief financial officer spent the earnings call making sure nobody mistook that result for a solved cost problem. The company beat earnings estimates by roughly 30%, and management raised full-year guidance well past ...

UnitedHealth Group stock has delivered a 54.8% return over the past year, yet the broader valuation checks point to a mixed picture rather than a straightforward bargain or clear overvaluation. UnitedHealth Group's 54.8% gain over the last 12 months puts recent buyers in a strong position, but it also raises the bar for what counts as good value from here. On the positive side, recent earnings strength and margin improvements can support the case that the current price still reflects...

Losing nearly one million Medicare Advantage members would normally be enough to send investors running. Not this time. Buried in UnitedHealth Group Inc’s second-quarter earnings report Thursday morning was a striking statistic: the company has lost 965,000 Medicare Advantage members...

The sticker price on CVS shares looks high, but the real question is what it costs on the earnings expected two years from now.

The health insurer raised its forecast after a solid quarter, but investors focused on the one business so broken it’s forcing a strategic retreat.

Jim Cramer named five blue-chip stocks the market punished after strong earnings, and he's betting that millions of investors and billions of dollars got it completely wrong.

Check out the companies making headlines this week:

The FDA just approved the first once-daily oral PCSK9 pill, and five major stocks now sit in the crosshairs. Not all of them come out ahead, and the biggest surprise winner may not be the company that makes the drug.

UnitedHealth Group's (UNH) Medicare Advantage business should continue to drive positive growth desp

UNH lifts its 2026 outlook as Medicare and Optum improve, while commercial cost pressures delay margin recovery and keep management focused on execution.

Wall Street closed lower on Thursday, dragged down by technology stocks, as investors assessed second-quarter earnings and a batch of economic data.

(Bloomberg) -- Circle Internet Group Inc. shares have lost more than three-quarters of their value from the highs seen just after their initial public offering last year and as more stablecoins come to market, one analyst is warning it could get worse.Most Read from BloombergThailand Scraps Plan to End Visa-Free Entry for Indian TouristsGoogle Gemini Launch Delayed as Tech Falls Short of Internal GoalsBeckham’s IM8 Gets $1 Billion From General Catalyst for GrowthCIA Says AI Drones Give Russian T

The company doubled its 2026 buyback target to at least $5 billion after already repurchasing $4 billion of shares.

Apple, AtaiBeckley and UnitedHealth Group jumped to yearly highs as positive company catalysts, Wall Street upgrades, and strong earnings pushed shares higher.

CEO Hemsley reports 55% operating earnings growth and raises full-year guidance.

UnitedHealth Group Incorporated will release earnings for its second quarter before the opening bell on Thursday, July 16. Analysts expect the company to report quarterly earnings of $4.85 per share, up from $4.08 per share in the year-ago period. The...

TSMC’s higher spending outlook raised concerns about near-term margins and returns in the ongoing AI infrastructure buildout.

Citi analysts laid out the appeal of biopharma stocks, with the NYSE Arca Pharmaceutical Index outrunning the S&P in the last month.

(Updates with closing levels throughout the story.) Wall Street's stock indexes fell Thursday aft

Shares of health insurance company UnitedHealth (NYSE:UNH) jumped 5.1% in the morning session after the company reported second-quarter earnings that surpassed Wall Street's expectations, driven by improved profitability.

Stronger medical costs and better-than-expected quarterly profit lifted guidance and boosted confidence in the earnings recovery.

U.S. stocks fell as a fresh wave of selling hit semiconductor stocks, overshadowing record earnings from Taiwan Semiconductor Manufacturing and strong results from UnitedHealth.

Taiwan Semiconductor Manufacturing posted its fifth straight quarter of record earnings earlier today, but that wasn’t enough to cheer investors. The Nasdaq slipped 1.5%, with Sandisk Western Digital and Marvell among the biggest losers. The PHLX Semiconductor index was off 4.3%.

While Taiwan Semi's post-earnings drop pressured chipmakers, healthcare names outperformed thanks to Merck's FDA win and Eli Lilly's big buy.

(Updates with index/price moves and geopolitical news from the first paragraph.) US equity indexe

UnitedHealth shares jumped to their highest level in more than a year Thursday after the health care and insurance giant reported better-than-expected quarterly results.

UnitedHealth Group Inc (UNH) reports a significant rise in adjusted EPS and operating earnings, while navigating cost pressures and strategic investments in AI.